We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Molecular Virus-Testing Platform Released in Europe

By HospiMedica staff writers
Posted on 03 Oct 2006
An automated branched DNA (bDNA) molecular system for viral-load testing of human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV) in serum and blood plasma is now available in Europe.

The system provides an easy-to-use molecular testing platform suitable for the general hospital and molecular laboratory. More...
Its touch screen interface and complete "load and go” bDNA automation includes on-board temperature control of assay reagents, on-board preparation of several assay reagents, and automated delivery of all assay reagents to micro wells. These features significantly reduce hands-on time and improve workflow and testing flexibility for mid- to high-volume laboratories.

This new system, called Versant 440, was developed by Bayer Healthcare, Diagnostics Division (Tarrytown, NY, USA), which is a subsidiary of Bayer AG (Leverkusen, Germany). It can process 12-168 patient samples per run and is compatible with a laboratory information system (LIS) through the Bayer bi-directional interface. The system has received the CE Mark.

"This addition allows us to offer a more robust portfolio with complete bDNA automation to the molecular diagnostics marketplace in Europe,” said Tony Bihl, president, Bayer Diagnostics. "The Versant 440 system reinforces Bayer Diagnostics' focus on satisfying the needs of hospitals and molecular laboratories.”



Related Links:
Bayer Healthcare

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.